The Pharmaceutics Department in the College of Pharmacy organized a panel discussion entitled (Evaluating the danger of excipients added to drugs for obtaining exceptional licenses from international authorities in the case of drugs falling within the first and third categories) with the participation of researchers and specialists.
The panel discussion included a lecture given by lecturer Nour Youssef Farid, which included an explanation of the concept of the biopharmaceutical classification system and the possibility of adopting it for the purpose of dispensing with bioavailability experiments in the case of manufacturing a local product based on medicines falling within the first and third categories in this classification, as well as a statement of the effect of inactive materials on availability. which may negatively affect the possibility of adopting this classification
Where the regulatory agencies set standards for biological equivalence in vivo and showed that the effects of inactive substances are more dangerous in the case of the third class than the first because they are weak in absorption. Therefore, it must be taken into account that the inactive substances used should be close to the original product in terms of type and quantity.
